CFDB - Cystic Fibrosis DataBase

  1. Home
  2. Database
Search (?)
at least one term
all terms
Advanced search
ongoing trials trial from www.clinicaltrials.gov

A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™) - Phase 2 - Not yet recruiting

  • Year: 2023
  • Date: February 14, 2022
  • Author: Boehringer Ingelheim
Source

https://ClinicalTrials.gov/show/NCT05865886

Study design (if review, criteria of inclusion for studies)

Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment

Participants

Cystic Fibrosis - 18 Years and older   (Adult, Older Adult)

Interventions

Drug: Exercise

Outcome measures

cardiorespiratory fitness assessment- Modified shuttle Walk test result|Ventilation defect percentage (VDP) as detected by 129Xenon MRI|forced expiratory volume in 1 second|quality of life assessment. Scale 0-100 (high score indicates better quality of life)|Exercise time

Keywords: exercise; Home; Home Care Services; non pharmacological intervention - devices OR physiotherapy; non pharmacological intervention - psyco-soc-edu-org; Ventilators; Organization;